Novo Nordisk Sales Rep Loses Retaliation Lawsuit
6 CommentsBy Ed Silverman // August 10th, 2010 // 7:43 am
Another day, another decision about retaliation in the workplace. This time, the conflict involves Novo Nordisk and Vivian Garriga, who joined the drugmaker as a diabetes sales rep in Florida in April 2001. She filed suit after being fired in September 2007, which she alleged in her lawsuit was in retaliation for complaining about her new supervisor’s sexual harassment. A federal district court dismissed her suit, however, and a federal appeals court has now upheld that decision, even while describing her former manager as “boorish.”
Here’s the story: Garriga was assigned to a new supervisor in March 2007 named Brian Taylor, who she alleged soon began a pattern of offensive behavior. As an example, Taylor asked everyone at his first district-wide staff meeting in early May (2007) to name the celebrity with whom they would like to have sex, according to court documents. During a ride-along - in which managers accompany reps on their rounds - he allegedly leered at her breasts and placed his arm around her in a parking lot.
Her lawsuit contends that he made “unwelcome sexual comments, talking about sexual intercourse and other sexual practices in business meetings and other work settings…regularly walking behind her, rather than next to her, so as to leer at her buttocks when the two were on sales visits together, calling (Garriga) and another female subordinate by sexually demeaning names, making threats, making unwelcome sexual advances, and verbally bullying (Garriga) with derision, yelling and cursing to the point where he caused her to cry.”
In July 2007, she complained to HR. Two weeks later, after Taylor learned of the complaint, she was placed on a 60-day coaching plan for poor sales performance. The next day, she complained to the same HR person, who allegedly responded by saying: “you are doing a lot better than what shows on (Taylor’s) coaching sheet.” So why was she fired? And why did the court uphold Novo’s argument?Crude behavior is not supposed to be condoned, right? The court, however, was not convinced that Taylor’s actions were not sufficiently eggregious to have created a hostile work environment.
The court emphasized that Taylor’s actions would have had to have been “sufficiently severe and pervasive to alter the terms or conditions of employment,” and that subjective perception must be objectively reasonable based on four factors: the frequency of the conduct; the severity of the conduct; whether the conduct is physically threatening or humiliating, or a mere offensive utterance; and whether the conduct unreasonably interferes with the employee’s job performance. While describing his conduct as “boorish,” the court decided three of four hurdles weren’t cleared (see the ruling).
Moreover, Garrgia also committed what most would consider a blunder….
That same July, Garriga and another rep sponsored a dinner at the home of one of her physician clients. Their boyfriends and the wife of at least one other physician also attended. “The dinner originally had been planned as a farewell dinner for a physician, but Garriga and Duffy arranged to pay for the meal as part of an informational training presentation,” according to court documents. Garriga argued Taylor was informed nine days in advance and had no complaints. But after her HR complained was filed, he complained to HR that the dinner violated PhRMA policies. By September, she was fired.
Truth
Unfortunately, the manager’s behavior seems to be quite typical of what is frequently encountered in the “frat-boy” environment that is Big Pharma sales. Also typical is that the employee who raises an issue to HR gets canned rather than the supervisor. HR stands for Hideous Retaliation in many companies. Gotta protect management and the compnany at all costs. Heck with the employee!
Justice in MI-Current CIAs
Not long ago, I wondered how many companies had current CIAs in place. I could not find the relevant thread, so I’m using this one in case people are interested. This is the list to the best I could determine it. Of course, I did not include device companies:
Pfizer and its recently acquired Wyeth, Merck, Schering-Plough, Bayer, Lilly, Novartis, Purdue, Bristol Myers Squibb, Aventis, Ivax, Cephalon, and AstraZeneca.
There are also expired CIAs for Abbott, GSK, and others.
Chris
It is interesting to consider how many of these firms actually are subject to multiple CIAs.
Used to work at Novo
Gee, I used to work at Novo and a friend and current employee there had unwanted sexual advances made on her and other women by a manager and I was encouraging her to report it. This story makes me think the company may side on the manager. No wonder rumor has it the manager has done this many times and the other “men” seemed to already know about it. Makes me glad I no longer work there. But this is possible in any work environment and women need to get better at documenting this behavior. As far as the dinner she did… that’s just poor judgement. Whether a manager approves or not, you are either within Pharma guidelines or out. That’s a judgement we can all make. In 2001 we all may have blurred the lines a bit. But in today’s time, none of us can afford to take that chance. Unfortunately, the manager saw a good and legal opportunity to fire his “trouble maker” and he knew he could get away with it. So, if you are going to report someone, you better have good documentation and keep a good record; don’t make it easy for them to fire you — it’s not right or fair, but it seems to be the way it goes. Successful women in the workforce are a threat to the few pathetic men still in power.
JP
Truth: Gee I wonder if you are a female or male and if you were ever terminated from a pharma sales position for improper expenses or falsification of calls? There is no biased in your posting at all is there! :)?
Seattle Pharma
Successful women in Pharma, how about the Novo rep in Sea Lorena Calvillo, when accountability was coming her way she filed suit against Purdue Pharma, and then contacted NY Times with stories of illegal marketing of Oxy, even had a note signed by Russ G. concerning diversion. What happened she got a check for $350,000 and no trial.
There are plenty of bad reps out there.